Stock Research for IPXL


Featured Broker: Ally Invest

Get the due diligence for another stock.


IPXL Stock Chart & Research Data

The IPXL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IPXL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


IPXL Due diligence Resources & Stock Charts

The IPXL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View IPXL Detailed Price Forecast - CNN Money CNN View IPXL Detailed Summary - Google Finance
Yahoo View IPXL Detailed Summary - Yahoo! Finance Zacks View IPXL Stock Research & Analysis -

Stock Analysis

TradeIdeas View IPXL Trends & Analysis - Trade-Ideas Barrons View IPXL Major Holders - Barrons
NASDAQ View IPXL Call Transcripts - NASDAQ Seeking View IPXL Breaking News & Analysis - Seeking Alpha
Spotlight View IPXL Annual Report - OTC Report View IPXL OTC Short Report -
TradeKing View IPXL Fundamentals - TradeKing Charts View IPXL SEC Filings - Bar Chart
WSJ View Historical Prices for IPXL - The WSJ Morningstar View Performance/Total Return for IPXL - Morningstar
MarketWatch View the Analyst Estimates for IPXL - MarketWatch CNBC View the Earnings History for IPXL - CNBC
StockMarketWatch View the IPXL Earnings - StockMarketWatch MacroAxis View IPXL Buy or Sell Recommendations - MacroAxis
Bullish View the IPXL Bullish Patterns - American Bulls Short Pains View IPXL Short Pain Metrics -

Social Media Mentions

StockTwits View IPXL Stock Mentions - StockTwits PennyStocks View IPXL Stock Mentions - PennyStockTweets
Twitter View IPXL Stock Mentions - Twitter Invest Hub View IPXL Investment Forum News - Investor Hub
Yahoo View IPXL Stock Mentions - Yahoo! Message Board Seeking Alpha View IPXL Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for IPXL - Insider Cow View Insider Transactions for IPXL - Insider Cow
CNBC View IPXL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for IPXL - OTC Markets
Yahoo View Insider Transactions for IPXL - Yahoo! Finance NASDAQ View Institutional Holdings for IPXL - NASDAQ

Stock Charts

FinViz View IPXL Stock Insight & Charts - StockCharts View IPXL Investment Charts -
BarChart View IPXL Stock Overview & Charts - BarChart Trading View View IPXL User Generated Charts - Trading View

Latest Financial News for IPXL

A Performance Overview of Merck’s Cardiovascular Segment
Posted on Thursday November 01, 2018

Merck & Co.’s (MRK) Zetia generated revenues of $165 million in the third quarter, reflecting a ~48% YoY (year-over-year) decline and a ~27% sequential decline. Zetia reported net revenues of $696 million in the first nine months of the year compared to $1 billion in the same period of 2017, reflecting a ~32% YoY decline.

Mylan’s EpiPen Supply Shortages Continue: What to Expect Ahead
Posted on Friday August 17, 2018

Mylan’s (MYL) epinephrine auto-injector EpiPen is approved as the first line of treatment for life-threatening allergic reaction anaphylaxis. During its second-quarter earnings release on August 8, Mylan provided an update on its EpiPen supply shortages.

How Is Merck’s Cardiovascular Portfolio Positioned after H1 2018?
Posted on Wednesday August 01, 2018

In the second quarter of 2018, Merck’s (MRK) Zetia generated revenues of $226.0 million compared to $367.0 million in the second quarter of 2017, reflecting a ~38% year-over-year (or YoY) decline and a ~26% sequential decline. In the second quarter of 2018, in the US and international markets (outside the US markets), Zetia generated revenues of $8.0 million and $218.0 million, respectively, compared to $122.0 million and $246.0 million in the second quarter of 2017.

What Is Impax Asset Management Group plc’s (LON:IPX) Share Price Doing?
Posted on Monday June 25, 2018

Impax Asset Management Group plc (LON:IPX), a capital markets company based in United Kingdom, led the AIM gainers with a relatively large price hike in the past couple of weeks.Read More...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.